Table 2.

Conservancy analysis of high-risk HPV L2 protein.

Protein Regions	Sequence and degree of conservancy
11–41 (Type 16)	KRASATQLYKTCKQAGTCPPDIIPKVEGKTI
	16	18	31	33	35	39	45	51	52	56	58	59	68
	100.00%	80.00%	76.67%	83.33%	86.67%	76.67%	80.00%	76.67%	83.33%	73.33%	73.33%	73.33%	73.33%
10–40 (Type 18)	KRASVTDLYKTCKQSGTCPPDVVPKVEGTTL
	16	18	31	33	35	39	45	51	52	56	58	59	68
	80.00%	100.0%	76.67%	76.67%	76.67%	90.00%	86.67%	83.33%	83.33%	73.33%	83.33%	83.33%	86.67%
96–120 (Type 16)	DPVGPSDPSIVSLVEETSFIDAGAP
	16	18	31	33	35	39	45	51	52	56	58	59	68
	100.00%	60.0%	76.00%	80.00%	76.00%	64.00%	64.00%	48.00%	64.00%	64.00%	80.00%	68.00%	60.00%
94–118 (Type 18)	EPVGPTDPSIVTLIEDSSVVTSGAP
	16	18	31	33	35	39	45	51	52	56	58	59	68
	60.00%	100.0%	64.0%	56.00%	52.0%	76.00%	92.00%	52.00%	56.00%	76.00%	60.00%	92.00%	80.00%
54–76 (Type 16)	FFGGLGIGTGSGTGGRTGYIPLG
	16	18	31	33	35	39	45	51	52	56	58	59	68
	100.00%	95.65%	86.96%	86.96%	86.67%	91.30%	86.96%	91.30%	78.26%	78.26%	95.65%	95.65%	91.30%
53–75 (Type 18)	FLGGLGIGTGSGTGGRTGYIPLG
	16	18	31	33	35	39	45	51	52	56	58	59	68
	95.65%	100.0%	82.61%	82.61%	82.61%	95.65%	91.30%	95.65%	73.91%	73.91%	91.30%	100.0%	67.86%
278–305 (Type 16)	APDPDFLDIVALHRPALTSRRTGIRYSR
	16	18	31	33	35	39	45	51	52	56	58	59	68
	100.00%	67.86%	85.71%	78.57%	82.14%	78.57%	64.29%	78.57%	82.14%	75.00%	89.29%	75.00%	82.14%
271–298 (Type 18)	VPDSDFMDIIRLHRPALTSRRGTVRFSR
	16	18	31	33	35	39	45	51	52	56	58	59	68
	67.86%	100.0%	78.57%	78.57%	78.57%	82.14%	96.43%	85.71%	85.71%	71.43%	78.57%	89.29%	85.71%